Park, S. H., Chi, H., Kwon, M., Cho, Y., Jang, S., & Park, C. (2012). Rare Frameshift Mutation Cys475Tyrfs(*)11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia. The Korean Society for Laboratory Medicine.
Citação norma ChicagoPark, Sang Hyuk, Hyun-Sook Chi, Mi-Ryang Kwon, Young-Uk Cho, Seongsoo Jang, and Chan-Jeoung Park. Rare Frameshift Mutation Cys475Tyrfs(*)11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients With Chronic Myelogenous Leukemia. The Korean Society for Laboratory Medicine, 2012.
Citação norma MLAPark, Sang Hyuk, et al. Rare Frameshift Mutation Cys475Tyrfs(*)11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients With Chronic Myelogenous Leukemia. The Korean Society for Laboratory Medicine, 2012.